Trademark: 97255444
Status Date
Wednesday, January 17, 2024
Filing Date
Monday, February 7, 2022
Published for Opposition
Tuesday, January 3, 2023
5 pharmaceutical preparations for the treatment of neurodegenerative, neuroinflammatory, neuromuscular, neurooncological, psychiatric, neurodevelopmental, neurometabolic, ophthalmologic, and central nervous system diseases and disorders
42 pharmaceutical research and development services
The mark consists of a double-helix design surrounded by a depiction of a human brain.
Color is not claimed as a feature of the mark.
Jan 19, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 17, 2024
Sou Extension 2 Granted
Jan 17, 2024
Sou Extension 2 Filed
Jan 17, 2024
Sou Teas Extension Received
Apr 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 26, 2023
Sou Extension 1 Granted
Apr 26, 2023
Sou Extension 1 Filed
Apr 26, 2023
Sou Teas Extension Received
Feb 28, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 3, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 3, 2023
Published For Opposition
Dec 14, 2022
Notification Of Notice Of Publication E-Mailed
Nov 29, 2022
Approved For Pub - Principal Register
Nov 18, 2022
Assigned To Examiner
Feb 12, 2022
Notice Of Design Search Code E-Mailed
Feb 11, 2022
New Application Office Supplied Data Entered
Feb 10, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
